SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-018781
Filing Date
2021-08-05
Accepted
2021-08-05 16:55:44
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20210630_10q.htm   iXBRL 10-Q 886400
2 EXHIBIT 31.1 ex_250732.htm EX-31.1 15822
3 EXHIBIT 31.2 ex_250733.htm EX-31.2 15392
4 EXHIBIT 32.1 ex_250734.htm EX-32.1 8599
  Complete submission text file 0001437749-21-018781.txt   4331900

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20210630.xsd EX-101.SCH 43636
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20210630_cal.xml EX-101.CAL 29618
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20210630_def.xml EX-101.DEF 311095
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20210630_lab.xml EX-101.LAB 273623
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20210630_pre.xml EX-101.PRE 323320
10 EXTRACTED XBRL INSTANCE DOCUMENT wint20210630_10q_htm.xml XML 569042
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 211149198
SIC: 2836 Biological Products, (No Diagnostic Substances)